VIRGINIA FARRAR: Open Payments
NPI 1750141198 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 30 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $308 · 2025 $581
Food & beverage: $581
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $227 |
| ABBVIE INC. | 9 | $154 |
| Melinta Therapeutics, LLC | 4 | $79 |
| Gilead Sciences, Inc. | 2 | $35 |
| Alexion Pharmaceuticals, Inc. | 1 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Amgen Inc. | 1 | $16 |
| Breas Medical, Inc. | 1 | $15 |
Products named: ELIQUIS, DALVANCE, Rezzayo, EMBLAVEO, Veklury, ULTOMIRIS, Kerendia, REPATHA.
Industry payments across AL — which companies pay providers there.
